X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 30/Aug 15:53

QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod

QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.

Articles similaires

Sorry! Image not available at this time

Travere Gains 11% on Securing Full FDA Nod for Kidney Disease Drug

zacks.com - 09/Sep 15:58

The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...

Sorry! Image not available at this time

Travere Gains 11% on Securing Full FDA Nod for Kidney Disease Drug

zacks.com - 09/Sep 15:58

The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...

Sorry! Image not available at this time

3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications

healthtechzone.com - 11/Sep 12:30

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Globant Boosts Portfolio With Strategic Buyouts: Will the Stock Gain?

zacks.com - 11/Sep 13:11

To strengthen its footprint in the financial services sector, which forms a major part of its business, GLOB announces the acquisition of Blankfactor.

Sorry! Image not available at this time

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

zacks.com - 03/Sep 13:42

QDEL's strong product portfolio raises optimism about the stock.

Sorry! Image not available at this time

Zynex Stock Rises on FDA Clearance of Its New Pain Management Device

zacks.com - 04/Sep 12:32

ZYXI recently received the Food and Drug Administration clearance for its new TensWave device. TensWave is designed to provide a comprehensive pain...

Sorry! Image not available at this time

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Sorry! Image not available at this time

ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down

zacks.com - 11/Sep 16:04

Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA for oral sulopenem to treat adult women with uUTI.

Les derniers communiqués